Australia markets closed

Tonix Pharmaceuticals Holding Corp. (TNXP)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.1770-0.0024 (-1.34%)
At close: 04:00PM EDT
0.1796 +0.00 (+1.47%)
Pre-market: 05:00AM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-108,091
-116,658
-110,218
-92,287
-50,463
Depreciation & amortisation
444
4,291
1,253
50
27
Stock-based compensation
10,494
9,275
10,914
7,899
2,876
Change in working capital
-1,044
-35
-2
5,781
-2,366
Inventory
61
61
0
-
-
Accounts payable
-3,923
-3,490
-1,045
3,526
1,528
Other working capital
-167,295
-109,898
-146,200
-110,864
-57,130
Other non-cash items
903
903
-
3,000
1,360
Net cash provided by operating activities
-98,197
-102,003
-98,053
-75,557
-48,566
Cash flows from investing activities
Investments in property, plant and equipment
-69,098
-7,895
-48,147
-35,307
-8,564
Acquisitions, net
-22,174
-22,174
0
-
-
Net cash used for investing activities
-69,098
-29,070
-48,147
-35,307
-8,564
Cash flows from financing activities
Common stock issued
128,597
18,939
94,463
212,389
108,605
Common stock repurchased
-13,965
-13,965
-47,250
0
-
Other financing activities
22,572
22,572
-
-
107,345
Net cash used provided by (used for) financing activities
124,382
36,517
87,844
212,487
123,105
Net change in cash
-42,992
-94,621
-58,430
101,592
65,959
Cash at beginning of period
183,210
120,470
178,900
77,308
11,349
Cash at end of period
140,297
25,849
120,470
178,900
77,308
Free cash flow
Operating cash flow
-98,197
-102,003
-98,053
-75,557
-48,566
Capital expenditure
-69,098
-7,895
-48,147
-35,307
-8,564
Free cash flow
-167,295
-109,898
-146,200
-110,864
-57,130